Available clinical data from the two adult patients dosed with TSHA-102 in the first cohort (low dose) to be discussed during upcoming quarterly earnings call following Independent Data Monitoring ...

The Food and Drug Administration on Wednesday approved Kite Pharma’s gene therapy, Yescarta, which uses patients’ genetically modified immune cells to fight cancer. Yescarta is approved to treat ...

Gene Hackman and the cover of his novel 'Pursuit' But Hackman also had a second career as a novelist, and he published several works of fiction throughout his lifetime. Hackman began his literary ...

Sarepta Therapeutics has suspended shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, to nonambulatory patients following a second reported death due to acute liver failure. The ...